📂 Drugs
rozanolixizumab — Definition
rozanoliksizumab / rozanolixizumab
Rozanoliksuzumab is a humanized monochlonal antibody, targeting autoantikors consisting of acetylcholine receptors in the crossroads of neuromuscular. By connecting to Neonatal Fc receptor (FcRn), immunooglobulin G (IgG) increases catabolism and lowers pathogenic IgG levels. Generally used in the treatment of generalized myastenia gravis (gMG), anti-acetilcholine receptor antibodies in positive adults. It is applied through intravenous infusion and requires caution in terms of side effects such as risk of infection during treatment.
Frequently Asked Questions
❓ What is rozanoliksizumab?
rozanoliksizumab; rozanoliksuzumab is a humanized monochlonal antibody, targeting autoantikors consisting of acetylcholine receptors in the crossroads of neuromuscular. By connecting to Neonatal Fc receptor (FcRn), immunooglobulin G (IgG) increases catabolism and lowers pathogenic IgG levels. Generally used in the treatment of generalized myastenia gravis (gMG), anti-acetilcholine receptor antibodies in positive adults. It is applied through intravenous infusion and requires caution in terms of side effects such as risk of infection during treatment.
❓ What is rozanolixizumab in Turkish?
The Turkish equivalent of "rozanolixizumab" is rozanoliksizumab.
❓ Which medical field is rozanoliksizumab related to?
This term belongs to the Drugs category.